Entrada Therapeutics, Inc. · NASDAQ:TRDA
Entrada Therapeutics, Inc. shareholders
As of Sep 30, 2026, 128 institutions reported holding Entrada Therapeutics, Inc., 79.0% of its shares. Largest: Baker Bros. Advisors LP, 5AM Venture Management, LLC and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Entrada Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 5.07M | 13.0% | no change | Nov 16, 2026 |
| 5AM Venture Management, LLC | 3.78M | 9.7% | −272K | Nov 16, 2026 |
| BlackRock | 3.24M | 8.3% | +654K | Nov 13, 2026 |
| Merck & Co., Inc. | 1.74M | 4.4% | no change | Nov 13, 2026 |
| Vanguard | 1.72M | 4.4% | +19,710 | Nov 13, 2026 |
| Trails Edge Capital Partners, LP | 1.43M | 3.6% | new | Nov 16, 2026 |
| TCG Crossover Management, LLC | 1.06M | 2.7% | no change | Nov 16, 2026 |
| Wellington | 954K | 2.4% | no change | Nov 16, 2026 |
| StepStone Group LP | 761K | 1.9% | no change | Nov 17, 2026 |
| Geode Capital | 708K | 1.8% | −8,940 | Nov 6, 2026 |